The good news is coming soon: the Oxford-made Corona Ticker trial has started on 10,000 people

[ad_1]

BanglaHunt Desk: One corona virus has shaken the whole world. University of Oxford professors are working day and night to find a vaccine for the corona virus. On April 23, researchers at the University of Oxford experimented with coronavirus on humans. The effectiveness of ChAdOx1 nCoV-19 was tested on 510 volunteers. The volunteers were kept under special observation for 15 days after the application of the vaccine. Researchers at the University of Oxford have found that the antidote did not cause any side effects or side effects. This time, in the second stage of the test, they want to take a closer look at the harmful side-effects of the antidote in the human body.

On April 23, researchers at the University of Oxford experimented with coronavirus on humans. The effectiveness of ChAdOx1 nCoV-19 was tested on 510 volunteers. The volunteers were kept under special observation for 15 days after the application of the vaccine. Researchers at the University of Oxford say the antidote did not cause any harmful side effects or side effects. This time, in the second stage of the test, they want to take a closer look at the harmful side-effects of the antidote in the human body.

Earlier, it was tested on monkeys in the laboratory, as well as in the experimental application of coronavirus made by Oxford University in the human body. The purpose was to see if there were any harmful side effects in the body from the application of this antidote. According to the scientists, good results have been found in this experiment. This antidote (ChAdOx1 nCoV-19) has been shown to prevent viral infections. However, researchers at the University of Oxford said that the use of the drug did not cause any adverse side effects in the monkeys. After that, the scientists are getting the confidence to test this antidote on humans in the final stage.

The success of this test depends on the commercial production of the corona antidote (ChAdOx1 nCoV-19) made by Oxford University and its use in the treatment of viruses. So the whole world is looking at the results of the second and final trial of the Corona Ticker made by Oxford University!

.

[ad_2]